More on MIRM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (7/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mirum Pharmaceuticals, Inc. (NQ:MIRM)
Delayed: 86.21 -1.63 (1.86%)
Prev. Close $87.84  
Open$86.01 
52 Wk High$ 
52 Wk Low$ 
Day High$88.86 
Day Low$85.76 
P/E N/A  
EPS$ 
Volume599,511 

Friends, Peers and Foes (?): ASND, BBIO, INSM, RCKT, RNA (more...)

Mar 5, 2026 09:18 AM Morgan Stanley Reiterates Overweight Rating on Mirum Pharmaceuticals (MIRM) amid study enrollment, screening completion
Mar 5, 2026 08:00 AM Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
Mar 4, 2026 08:27 AM Mirum Pharmaceuticals (MIRM) PT Raised to $126 at Evercore ISI
Feb 26, 2026 10:52 AM Mirum Pharmaceuticals (MIRM) PT Lowered to $118 at Leerink Partners
Feb 26, 2026 10:50 AM Mirum Pharmaceuticals (MIRM) Defended by Second Outlet, This time from Evercore: 'we think the move down is noise in a volatile tape this morning.'
Feb 26, 2026 10:40 AM RBC Capital Defending Mirum Pharmaceuticals (MIRM) Amid 15% Drop: 'Buying Opportunity Ahead of Multiple De-risked Catalysts'
Feb 26, 2026 10:22 AM Mirum Pharmaceuticals (MIRM) PT Raised to $117 at TD Cowen
Feb 26, 2026 08:40 AM Mirum Pharmaceuticals (MIRM) PT Raised to $130 at Morgan Stanley
Feb 26, 2026 08:20 AM Mirum Pharmaceuticals (MIRM) PT Raised to $125 at Stifel
Feb 26, 2026 07:42 AM Mirum Pharmaceuticals (MIRM) PT Lowered to $128 at RBC Capital
View All Articles

Entities mentioned with MIRM

View All Entities